- Home>
- Reader Remarks
Reader Remarks on:
The HORIZON Study: Bisphosphonates for Patients on Corticosteroids
how about pediatric patients
TL Lee, 10 May 2009 10:58 PM EST
Competing interests: None declared
what is your recommendation in pediatrics patients receiving high dose corticosteroid?
pediatric patients
Jeffrey Callen, University of Louisville; Deputy and Feature Editor, Journal Watch Dermatology, 12 May 2009 4:05 PM EST
Competing interests: None declared
Bone loss is a potential problem for these patients as well, but even more of an issue is the stunting of growth. The bisphosphonates are not approved for use in children, therefore you should discuss their use carefully with the patient's primary provider and assess the risks before prescribing.
Potential adverse effect of zelodronic acid
FC Payne, 1 Jan 2010 11:35 PM EST
Competing interests: None declared
I think I recall that zelodronic acid has been more frequently used in the treatment of osteoporosis in cancer patients than bisphosphonates. Jaw bone necrosis has occured, I recall, much more frequently in the zelodronic/cancer population than the bisphpsphonate/ cancer-free population.
Your Remark:
To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

